ژورنال کلاب های سال 1400
|
ردیف |
عنوان |
ارائه دهنده |
تاریخ |
تک برگ خلاصه مقاله |
|
1 |
Management of Dyslipidemia for Cardiovascular Disease Risk Reduction: Synopsis of the 2020 Updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline |
دکتر زراعتکار |
1400/01/26 |
click |
|
2 |
The effects of opium on the cardiovascular system: a review of side effects, uses, and potential mechanisms |
دکتر تورجی |
1400/02/09 |
click |
|
3 |
Association of Statin Use With Disability-Free Survival and Cardiovascular Disease Among Healthy Older Adults Evaluation of Time to Benefit of Statins for the Primary Prevention of Cardiovascular Events in Adults Aged 50 to 75 Years A Meta-analy |
دکتر اخوان دکتر حاجیان |
1400/02/30 |
click |
|
4 |
The antiphospholipid syndrome – often overlooked cause of vascular occlusions? |
دکتر نصرتی دکتر سیاه مشته |
1400/03/13 |
click |
|
5 |
Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis |
دکتر رفعتی |
1400/03/27 |
click |
|
6 |
Glycated Hemoglobin and Subclinical Atherosclerosis in People Without Diabetes |
دکتر خداپرست |
1400/04/10 |
click |
|
7 |
Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes |
دکتر دریایی |
1400/04/17 |
click |
|
8 |
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation |
دکتر تورجی |
1400/04/24 |
click |
|
9 |
Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the predictors of outcomE: The Ultra-slow PROMETEE trial Comparison of Different TEE-Guided Thrombolytic Regimens for Prosthetic Valve Thrombosis |
دکتر عباسی دکتر شهسوارپور |
1400/05/14 |
click |
|
10 |
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation (17. Atrial fibrillation patients presenting with acute stroke while on non-vitamin K antagonist oral Anticoagulants) |
دکتر رفعتی |
1400/05/21 |
click |
|
11 |
Features, Evaluation, and Treatment of Coronavirus Neutralizing monoclonal antibodies for treatment of COVID-19 |
دکتر ثقفی دکتر رعنایی |
1400/06/11 |
click |
|
12 |
Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study |
دکتر رفعتی |
1400/06/18 |
click |
|
13 |
Patient-tailored antithrombotic therapy following percutaneous coronary intervention |
دکتر تورجی |
1400/06/24 |
click |
|
14 |
Patient-tailored antithrombotic therapy following percutaneous coronary intervention |
دکتر تورجی |
1400/07/01 |
click |
|
15 |
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension |
1400/07/22 |
click |
|
|
16 |
مقایسه اثرات درمان محافظتی در مقابل درمان تهاجمی در بیماران CAD پایدار |
1400/08/05 |
click |
|
|
17 |
P Wave Indices-Advancing Our Understanding of Atrial Fibrillation-Related Cardiovascular Outcomes |
دکتر اخوان |
1400/08/13 |
click |
|
18 |
Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial |
دکتر رحمانی |
1400/09/03 |
click |
|
19 |
Effect of Empagliflozin on Worsening Heart |
دکترمعزی- دکتر اکبری |
1400/10/09 |
click |
|
20 |
6سوال بالینی مطرح شده: 1-جایگزینیR+PA به جای Altplدرترومبوز دریچه 2-بررسی STEدرلیدAVRدربیمارانACS 3-مطالعه دروس علوم پزشکی به زبان Non nativeیا Nativeدر دانشجویان پزشکی 4-درمان با Coronarysyn post acute Atorvast vs high intensity Ropix 5-تاثیر Physical activity Exercise برروی کیفیت زندگی بیماران 6-تاثیر Depression And Anxiety در pre mature CAD |
Pico-cat |
1400/11/14 |
click |
|
21 |
1-Cordovez RA. Association of aVR ST-elevation with outcomes in patients with acute coronary syndrome. 2- Wang A ,et al.Prognostic implications of ST-segment elevation in lead aVR in patients with acute coronary syndrome: A meta-analysis. 3-- Adem Adar et al. Relationship between ST-Segment Shifts in Lead aVR and Coronary Complexity in Patients with Acute Coronary Syndrome. 4--Jennifer J. Et al,aVR ST Segment Elevation: Acute STEMI or Not? Incidence of an Acute Coronary Occlusion, .5- Ko W, Hurng G, Zhou R, et al. A Systematic Approach to Evaluate Patients Presenting With ST-Segment Elevation in Lead aVR: A Case Series. 6- Hiltner E ,et al. Is isolated ST segment elevation in Lead aVR associated with high grade coronary artery disease? |
Pico-cat |
1400/11/21 |
click |
|
22 |
Segment Elevation: Acute STEMI or Not? Incidence of an Acute Coronary Occlusion, |
Pico-cat |
1400/11/28 |
click |